CapsoVisionCV -1.69%10 Days Payable is 78.03 as of Mar. 2026, which is 107% above its 10-year median of 37.66. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, CapsoVision ranks worse than 52.7% on this metric.
The historical rank and industry rank for CapsoVision's Days Payable or its related term are showing as below:
CV'
s Days Payable Range Over the Past 10 Years
Min: 30.92 Med: 37.66 Max: 65.56
Current: 65.56
During the past 3 years, CapsoVision's highest Days Payable was 65.56. The lowest was 30.92. And the median was 37.66.
CV's Days Payable is ranked worse than 52.7% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs CV: 65.56
CapsoVision's Days Payable
increased
from Mar. 2025 (57.77) to Mar. 2026 (78.03).
It may suggest that CapsoVisiondelayed paying its suppliers.
CapsoVision Days Payable Related Terms
CapsoVision Days Payable Historical Data
* Premium members only.
The historical data trend for CapsoVision's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CapsoVision's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CapsoVision Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CapsoVision's Days Payable distribution charts can be found below:
* The bar in red indicates where CapsoVision's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CapsoVision's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CapsoVision (CV) has a Days Payable of 78.03 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CapsoVision and its competitors. This is 107% above median its historical median of 37.66. Over the past decade, CapsoVision's Days Payable has ranged from 30.92 to 65.56. According to the industry distribution chart, CapsoVision ranks #419 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 52.7%.
Is CapsoVision's Days Payable too high?
CapsoVision's current Days Payable of 78.03 is 107% above median its 10-year median of 37.66. Over the past 10 years, this metric has ranged from a low of 30.92 to a high of 65.56. The Medical Devices & Instruments industry median Days Payable is 67.87. CapsoVision's value of 78.03 is 15% above this industry median. Based on the distribution chart, CapsoVision ranks #419 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's Days Payable compare to SENS and MASS?
According to the Medical Devices & Instruments industry distribution chart, CapsoVision ranks #419 out of 795 companies for Days Payable. This places CapsoVision in the lower half of its industry. The industry median Days Payable is 67.87. CapsoVision's value of 78.03 is 15% above this benchmark. Historically, CapsoVision's own Days Payable has ranged from 30.92 to 65.56 over the past decade. While the company's 10-year median is 37.66 vs. the industry median of 67.87, CapsoVision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CapsoVision's current Days Payable of 78.03 is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CapsoVision and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CapsoVision's current Days Payable is 78.03, which is 107% above median its own 10-year median of 37.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current Days Payable of 78.03. The current Days Payable is 78.03, which is 107% above median its 10-year median of 37.66 and 15% above the Medical Devices & Instruments industry median of 67.87. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CapsoVision (CV), the current Days Payable is 78.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score
Get the complete analysis for CV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CV has been successfully added to your 
